{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T05:53:42Z","timestamp":1723355622584},"reference-count":38,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,18]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Type I IFN preconditioning enhances HSC engraftment efficiency. IFN-based pre-transplant conditioning is applicable to the treatment of Sly syndrome.<\/jats:p>","DOI":"10.1182\/blood-2012-07-443713","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T03:27:19Z","timestamp":1360898839000},"page":"3267-3273","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Novel interferon-based pre-transplantation conditioning in the treatment of a congenital metabolic disorder"],"prefix":"10.1182","volume":"121","author":[{"given":"Taku","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Biodefense Research, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan;"},{"name":"Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahoko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Biodefense Research, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yotsumoto","sequence":"additional","affiliation":[{"name":"Department of Biodefense Research, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohta","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy, Institute of DNA Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Genetic Diseases and Genome Science,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy, Institute of DNA Medicine,"},{"name":"Department of Genetic Diseases and Genome Science,"},{"name":"Department of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Neuroscience, Research Center of Medical Science, The Jikei University School of Medicine, Tokyo, Japan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Gene Therapy, Institute of DNA Medicine,"},{"name":"Department of Genetic Diseases and Genome Science,"},{"name":"Department of Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Suda","sequence":"additional","affiliation":[{"name":"Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ohteki","sequence":"additional","affiliation":[{"name":"Department of Biodefense Research, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan;"},{"name":"Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST), Tokyo, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"2","key":"2019111818022864300_B1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007890-198808000-00004","article-title":"Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan.","volume":"46","author":"Mauch","year":"1988","journal-title":"Transplantation"},{"key":"2019111818022864300_B2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bmb\/ldl005","article-title":"Allogeneic haematopoietic stem cell transplantation: current status and future outlook.","volume":"77-78","author":"Aschan","year":"2006","journal-title":"Br Med Bull"},{"key":"2019111818022864300_B3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/asheducation.V2000.1.319.20000319","article-title":"Bone Marrow Transplantation for Non-Malignant Disease.","author":"Sullivan","year":"2000","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"6791","key":"2019111818022864300_B4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","article-title":"Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.","volume":"406","author":"May","year":"2000","journal-title":"Nature"},{"key":"2019111818022864300_B5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1196\/annals.1345.007","article-title":"A phase I\/II clinical trial of beta-globin gene therapy for beta-thalassemia.","volume":"1054","author":"Bank","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2019111818022864300_B6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V83.3.828.828","article-title":"Hematopoietic repopulation of adult mice with beta-thalassemia.","volume":"83","author":"Barker","year":"1994","journal-title":"Blood"},{"issue":"10","key":"2019111818022864300_B7","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood.V84.10.3311.3311","article-title":"Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells.","volume":"84","author":"Kume","year":"1994","journal-title":"Blood"},{"issue":"5","key":"2019111818022864300_B8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex vivo gene transfer and correction for cell-based therapies.","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2019111818022864300_B9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.2910320215","article-title":"Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats.","volume":"32","author":"Berger","year":"1983","journal-title":"Int J Cancer"},{"issue":"7240","key":"2019111818022864300_B10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo.","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"issue":"3","key":"2019111818022864300_B11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2726","article-title":"Awakening dormant haematopoietic stem cells.","volume":"10","author":"Trumpp","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2019111818022864300_B12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.","volume":"15","author":"Sato","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"2019111818022864300_B13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis.","volume":"82","author":"Sly","year":"1973","journal-title":"J Pediatr"},{"issue":"5","key":"2019111818022864300_B14","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood-2002-08-2597","article-title":"Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease.","volume":"101","author":"Hofling","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111818022864300_B15","first-page":"969","article-title":"Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.","volume":"82","author":"Glaser","year":"1973","journal-title":"J Lab Clin Med"},{"issue":"2","key":"2019111818022864300_B16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0003-2697(89)90061-4","article-title":"Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography.","volume":"177","author":"Yoshida","year":"1989","journal-title":"Anal Biochem"},{"issue":"2","key":"2019111818022864300_B17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0092-8674(90)90163-9","article-title":"Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.","volume":"63","author":"Harada","year":"1990","journal-title":"Cell"},{"issue":"5","key":"2019111818022864300_B18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha\/beta signaling.","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"issue":"2","key":"2019111818022864300_B19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1073\/pnas.73.2.630","article-title":"The mucopolysaccharidoses (a review).","volume":"73","author":"Dorfman","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111818022864300_B20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymthe.2005.02.031","article-title":"Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice.","volume":"12","author":"Orii","year":"2005","journal-title":"Mol Ther"},{"issue":"1","key":"2019111818022864300_B21","first-page":"207","article-title":"A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice.","volume":"136","author":"Vogler","year":"1990","journal-title":"Am J Pathol"},{"issue":"6","key":"2019111818022864300_B22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1634\/stemcells.2006-0808","article-title":"Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.","volume":"25","author":"Barese","year":"2007","journal-title":"Stem Cells"},{"issue":"5854","key":"2019111818022864300_B23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"issue":"24","key":"2019111818022864300_B24","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1182\/blood-2010-07-295949","article-title":"Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.","volume":"116","author":"Xue","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111818022864300_B25","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood.V89.7.2376","article-title":"Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment.","volume":"89","author":"van Os","year":"1997","journal-title":"Blood"},{"issue":"12","key":"2019111818022864300_B26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.exphem.2004.08.007","article-title":"A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.","volume":"32","author":"Goebel","year":"2004","journal-title":"Exp Hematol"},{"issue":"26","key":"2019111818022864300_B27","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1056\/NEJMoa1004095","article-title":"Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.","volume":"363","author":"Preudhomme","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111818022864300_B28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"issue":"21","key":"2019111818022864300_B29","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.febslet.2009.10.006","article-title":"Interferon regulatory factor-2 induces megakaryopoiesis in mouse bone marrow hematopoietic cells.","volume":"583","author":"Masumi","year":"2009","journal-title":"FEBS Lett"},{"issue":"4","key":"2019111818022864300_B30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.0107014","article-title":"Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage.","volume":"82","author":"Liu","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2019111818022864300_B31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35073080","article-title":"A weak signal for strong responses: interferon-alpha\/beta revisited.","volume":"2","author":"Taniguchi","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2019111818022864300_B32","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/annonc\/mdf288","article-title":"Phase II trial of branched peginterferon-\u03b1 2a (40 kDa) for patients with advanced renal cell carcinoma.","volume":"13","author":"Motzer","year":"2002","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111818022864300_B33","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.2001.19.5.1312","article-title":"Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.","volume":"19","author":"Motzer","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111818022864300_B34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa0707255","article-title":"Chimerism and tolerance in a recipient of a deceased-donor liver transplant.","volume":"358","author":"Alexander","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"2019111818022864300_B35","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model.","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"2019111818022864300_B36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev.med.56.090203.104142","article-title":"Gene therapy for severe combined immunodeficiency.","volume":"56","author":"Cavazzana-Calvo","year":"2005","journal-title":"Annu Rev Med"},{"issue":"6","key":"2019111818022864300_B37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ymthe.2005.09.007","article-title":"Correction of murine hemophilia A by hematopoietic stem cell gene therapy.","volume":"12","author":"Moayeri","year":"2005","journal-title":"Mol Ther"},{"issue":"9","key":"2019111818022864300_B38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/14712598.4.9.1423","article-title":"Gene therapy for chronic granulomatous disease.","volume":"4","author":"Barese","year":"2004","journal-title":"Expert Opin Biol Ther"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/16\/3267\/1330002\/3267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/16\/3267\/1330002\/3267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T23:02:57Z","timestamp":1574118177000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/16\/3267\/31620\/Novel-interferonbased-pretransplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2013,4,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-07-443713","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]}}}